Skip to main content
Log in

Prognostic factors for recurrence and survival in human breast cancer

  • 9th San Antonio Breast Cancer Symposium: Plenary lecture
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Since only about half of primary breast cancer patients are cured by local treatment, factors which can predict which patients are likely to recur and should thus receive preventive treatmrnt are needed. Here, work on such prognostic factors which has been going on in San Antonio for many years will be reviewed. The significance of the number of involved axillary nodes and of steroid receptors is already well known, while the value of tumor proliferative rate and ploidy has been appreciated more recently, and the significance of amplification of the oncogene HER-2/neu is just now emerging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Knight, WA III, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671, 1977

    Google Scholar 

  2. Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS: Progesterone receptor as a prognostic factor in Stage II breast cancer. N Engl J Med 309: 1343–1347, 1983

    PubMed  Google Scholar 

  3. Meyer JS: Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma. NCI Monogr 1: 25–28, 1986

    PubMed  Google Scholar 

  4. Silvestrini R, Daidone MG, DiFronzo G, Morabito A, Valagussa P, Bonadonna G: Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat 7: 161–169, 1986

    PubMed  Google Scholar 

  5. Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP: The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer 33: 441–445, 1984

    PubMed  Google Scholar 

  6. McGuire WL, Meyer JS, Barlogie B, Kute TE: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 5: 117–128, 1985

    PubMed  Google Scholar 

  7. McGuire WL, Dressler LG: The emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 75: 405–410, 1985

    PubMed  Google Scholar 

  8. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Amplification of the HER-2/neu oncogene correlates with relapse and survival in human breast cancer. Science 235: 177–182, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGuire, W.L. Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Tr 10, 5–9 (1987). https://doi.org/10.1007/BF01806129

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806129

Key words

Navigation